LH
Laboratory Corporation of America Holdings
NYSE: LH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$257.14
-0.94% today
Updated 2026-04-29
Market cap
$21.19B
P/E ratio
24.56
P/S ratio
1.52x
EPS (TTM)
$10.47
Dividend yield
1.11%
52W range
$237 – $292
Volume
0.6M
Laboratory Corporation of America Holdings (LH) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $4.00B | $4.37B | $4.67B | $4.86B | $6.19B | $6.17B | $6.81B | $6.95B | $7.30B | $14.29B | $14.25B | $16.57B | $16.19B | $18.02B | $20.07B | $20.39B | $20.16B | $16.73B | $18.38B | $18.39B |
| Cash & equivalents | $51.50M | $56.40M | $219.70M | $148.50M | $230.70M | $159.30M | $466.80M | $404.00M | $580.00M | $716.40M | $433.60M | $316.60M | $426.80M | $337.50M | $1.32B | $1.47B | $320.60M | $536.80M | $1.52B | $532.30M |
| Current assets | $887.00M | $937.50M | $1.03B | $722.70M | $886.30M | $859.10M | $1.19B | $1.19B | $1.69B | $2.66B | $2.48B | $2.68B | $2.84B | $2.98B | $5.13B | $5.33B | $4.63B | $3.77B | $4.81B | $4.02B |
| Total liabilities | $2.02B | $2.64B | $2.86B | $2.61B | $3.55B | $3.65B | $4.06B | $4.47B | $4.46B | $9.14B | $8.73B | $9.85B | $9.19B | $10.46B | $10.61B | $10.09B | $10.04B | $8.83B | $10.31B | $9.76B |
| Current liabilities | $930.90M | $967.90M | $546.90M | $2.61B | $2.19B | $3.65B | $1.03B | $735.70M | $976.30M | $1.70B | $1.83B | $2.19B | $1.88B | $2.66B | $3.08B | $2.78B | $3.08B | $3.23B | $3.33B | $2.82B |
| Long-term debt | $603.00M | $1.08B | $1.60B | $977.20M | $1.83B | $2.09B | $2.17B | $2.89B | $2.68B | $5.99B | $5.30B | $6.34B | $6.04B | $5.79B | $5.42B | $5.42B | $5.04B | $4.05B | $5.33B | — |
| Shareholder equity | $1.98B | $1.73B | $1.69B | $2.11B | $2.47B | $2.50B | $2.72B | $2.48B | $2.82B | $4.95B | $5.51B | $6.80B | $6.97B | $7.57B | $9.44B | $10.27B | $10.10B | $7.88B | $8.05B | $8.62B |
| Retained earnings | $1.77B | $2.24B | $2.60B | $2.93B | $3.25B | $3.39B | $3.59B | $3.37B | $3.79B | $4.22B | $4.96B | $6.22B | $7.08B | $7.90B | $9.48B | $10.46B | $10.58B | $7.89B | $8.30B | $8.64B |
| Accounts receivable | $541.30M | $623.20M | $631.60M | $574.20M | $655.60M | $699.80M | $718.50M | $784.70M | $815.70M | $1.37B | $1.52B | $1.85B | $1.86B | $2.03B | $3.02B | $2.98B | $2.00B | $2.10B | $2.10B | $2.26B |
| Inventory | $84.30M | $80.40M | $91.00M | $90.00M | $103.40M | $110.80M | $121.00M | $136.50M | $139.50M | $191.00M | $205.20M | $227.60M | $237.30M | $244.70M | $423.20M | $401.40M | $470.60M | $474.60M | $493.20M | $534.70M |
| Goodwill | $1.48B | $1.64B | $1.77B | $1.90B | $2.60B | $2.68B | $2.90B | $3.02B | $3.10B | $6.29B | $6.42B | $7.53B | $7.36B | $7.87B | $7.75B | $7.96B | $6.12B | $6.14B | $6.37B | $6.79B |